Cytokine gene expression during the development of graft coronary artery disease in mice.
Immunologic injury to heart allografts is an initial and essential event in the pathogenesis of graft coronary artery disease (GAD). A variety of cytokines expressed in heart allografts modify both acute rejection and chronic inflammation, and could contribute to the development of GAD. The present study investigated the gene expression of interleukin (IL)-1beta, IL-2, IL-4, IL-6, IL-10, tumor necrosis factor (TNF)-alpha, interferon (IFN)-gamma, and Fas ligand in chronically rejecting DBA/2-to-B 10.D2 mouse heart allografts at defined intervals of 7, 14, 28, or 70 days after transplantation by semiquantitative reverse transcriptase-polymerase chain reaction. GAD developed gradually, showing the highest value for mean intima/media ratio at day 70. Fas ligand, and the Th1 cytokines IL-2 and IFN-gamma, were vigorously induced in allografts at day 7, when histology showed pronounced parenchymal rejection, and rapidly decreased by day 28. However, the level of mRNA expression of Th2 cytokines, IL-6 and IL-10, and other inflammatory cytokines, TNF-alpha and IL-1beta, were still elevated on day 28. The persistent expression of specific cytokines suggests an important role in chronic inflammation. Thus, a persistently high level expression of inflammatory cytokines could be associated with chronic inflammation in the allografts, which promotes the development of GAD.
Furukawa
Y
Y
Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Japan.
Matsumori
A
A
Hwang
M W
MW
Hirozane
T
T
Ono
K
K
Shioi
T
T
Sasayama
S
S
D000818:Animals; D000954:Antigens, Surface / Q000235:genetics; D015139:Blotting, Southern; D003327:Coronary Disease / Q000209:etiology* / Q000473:pathology*; D016207:Cytokines / Q000235:genetics*; D004247:DNA / Q000032:analysis; D004195:Disease Models, Animal; D053222:Fas Ligand Protein; D005786:Gene Expression Regulation; D006084:Graft Rejection / Q000235:genetics*; D016027:Heart Transplantation / Q000009:adverse effects* / Q000276:immunology; D007371:Interferon-gamma / Q000235:genetics; D007378:Interleukins / Q000235:genetics; D008024:Ligands; D008262:Macrophage Activation / Q000502:physiology; D008264:Macrophages; D008297:Male; D008562:Membrane Glycoproteins / Q000235:genetics; D051379:Mice; D008811:Mice, Inbred DBA / Q000235:genetics / Q000601:surgery*; D012333:RNA, Messenger / Q000032:analysis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013997:Time Factors; D014184:Transplantation, Homologous / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics
D000954:Antigens, Surface; D016207:Cytokines; D053222:Fas Ligand Protein; C505658:Fasl protein, mouse; D007378:Interleukins; D008024:Ligands; D008562:Membrane Glycoproteins; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma; D004247:DNA